Ron DeSantis Was Right about Monoclonal-Antibody Therapy

Florida’s governor was blasted by progressives for promoting Regeneron’s COVID treatment. Now, demand is so great the Biden administration is rationing it.

Share this story

President Joe Biden participates in a briefing alongside Florida’s Governor Ron DeSantis, in Miami, Fla., July 1, 2021.

Kevin Lamarque/Reuters

Two months ago, Governor Ron DeSantis of Florida was being roundly castigated for promoting the use of Regeneron’s monoclonal-antibody treatment as part of his state’s efforts to fight COVID-19. Desperate to find something sinister in the push, DeSantis’s critics threw out every charge they could dream up. At first, the line was that Regeneron’s treatment didn’t work. Then, it was that Regeneron’s treatment worked fine, but represented a dangerous distraction from the vaccine. And, finally, it was that Regeneron’s treatment was part of a corrupt plot to enrich DeSantis’s donors.

Today, we learn from the Washington Post that, actually, none of that was the problem. Instead, DeSantis’s sin is that he has been relying upon monoclonal-antibody treatment too much, and that this is unfair to other states that now need it.

Charles C. W. Cooke

About the Author

Charles C. W. Cooke

Charles C. W. Cooke is a senior editor at National Review and the host of The Charles C. W. Cooke Podcast.

Comments

Advertisement

Advertisement